Programme of the EAU 5th South Eastern European Meeting (SEEM)

        Friday, 9 October 2009

        Tabled 1
        09.00–09.10Welcome and introduction
        Ch. Chapple, Sheffield
        S. Micic, Belgrade
        9.10–10.10Bladder cancer
        Bladder cancer is not what it used to be, L. Turkeri, Istanbul
        Management of non-muscle invasive disease, A. Vuksanovic, Belgrade
        Reducing morbidity of radical prostatectomy, A. Hinev, Varna
        10.10–10.40Debate. Urinary diversion at cystectomy: Continent is the way to go
        Wet: M. Marberger, Vienna
        Dry: T. Esen, Istanbul
        10.40–11.10Coffee break and mounting, viewing of posters
        Tabled 1
        10.40–12.40Poster sessions 1: Bladder cancer and urinary diversionRoom 1
        S1.The expression of Cyclooxygenase 2 (COX-2) in myofibroblasts surrounding bladder carcinomas: from “reactive neighbourhood” to “active contributor”, S. Kontos*, A. Kominea, K. Balampanis, V. Simaioforidis, G. Lefakis, V. Politis, I. Fokitis, G. Sotiropoulou-Bonikou (Piraeus, Aegion, Athens, Patras)
        S2.Evaluation of the clinical value of urinary NMP22 as a marker in the surveillance of superficial transitional cell carcinoma of the urinary bladder, A. Janjic*, N. Lalic, B. Glisic, M. Jovanovic, N. Bojanic, S. Micic (Belgrade)
        S3.Urine IL8 concentration correlates with advanced bladder tumors, D. Vojvodic, R. Milosevic*, I. Stanojevic, Z. Magic, I. Majstorovic, N. Milovic (Belgrade)
        S4.Chronic inflammation and bladder cancer: How hot is the link?, S. Kontos*, A. Kominea, K. Balampanis, V. Politis, V. Simaioforidis, I. Fokitis, G. Sotiropoulou-Bonikou (Peiraeus, Aegion, Athens, Patras)
        S5.Primary adenocarcinoma of the urinary bladder. Presentation of 5 cases, I. Xoxakos*, G. Sotiropoulou, D. Rompolis, V. Chatzinikolaou, C. Fliatouras, C. Kalyvas, D. Stokidis (Korinthos)
        S6.Urachal carcinoma of bladder, A. Ilievski*, P. Ilievski (Skopje; Vernal, Utah)
        S7.Bladder endometriosis: which treatment?, C. Ammendola*, R. Falabella, S. Lioi, M. Muscillo (Potenza)
        S8.Quality of life after radical cystectomy, S. Vojinov*, D. Jeremic, I. Levakov, S. Zivojinov, J. Djozic, G. Marusic (Novi Sad)
        S9.Radical cystectomy – analyses of postoperative complications, D. Jeremic*, S. Vojinov, I. Levakov, N. Dejanovic, S. Zivojinov, M. Popov, G. Marusic (Novi Sad)
        S10.Smaller vs. standard ileal orthotopic neobladder after cystectomy, V. Bancevic*, P.R. Aleksic, N. Milovic, B.J. Kosevic, Z. Campara, M. Jovanovic, D. Stamenkovic (Belgrade)
        S11.Urodynamic features of Hautmann orthotopic ileal neobladder using standard and ambulatory urodynamics. Preliminary results, A. Malioris*, G. Dimitriadis, G. Gkotsos, A. Anastasiadis, C. Papastavros, A. Karamitsou, D. Radopoulos (Thessaloniki)
        S12.Continental derivation of urine in children using the method of Mitrofanoff, S. Tchanatchev, E. Atanasov*, S. Peev, G. Minova (Sofia)
        S13.Postirradiation vesicovaginal fistulas, N. Dejanovic*, S. Zivojinov, G. Marusic, S. Vojinov, J. Djozic, D. Jeremic (Novi Sad)
        S14.Operative treatment of the bladder exstrophy by the method of Arap in childhood age, S. Tshanatshev*, S. Peev, G. Minova, E. Atanasov, V. Popov (Sofia)
        S15.Percutaneous nephrostomy: a tool for treatment of obstruction and a source of infection. An interdisciplinary approach, S. Dyakov, P.K. Chankov*, V.H. Ikonomov, A.I. Hinev (Varna)
        Tabled 1
        10.40–12.40Poster sessions 2: BPH and prostate biopsyRoom 2
        S16.The influence of three different medications for benign prostatic hyperplasia on prostate parameters assessed by transabdominal ultrasound, B. Pajovic*, N. Duborija-Kovacevic (Podgorica)
        S17.Autonomic nervous system activity in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia estimated by heart rate variability, K. Juszczak*, M. Mazur, M. Wyczółkowski, P.J. Thor (Cracow)
        S18.Treatment of BPH with transurethral bipolar vaporization in saline (, S.T. Leontis*, C. Fasoulakis, A. Leventis, L. Leonardopoulos, G. Diamantis, A. Rempelakos (Athens)
        S19.Urodynamic evaluation on patients with chronic pelvic pain syndrome, I. Vukovic*, D. Djordjevic, P. Nikic, D. Nale (Belgrade)
        S20.Frequency of LUTS/BPH in men aged between 50 to 80 years, P.Z. Nikic*, D. Nale, O. Durutovic, A. Vuksanovic, S. Micic (Belgrade)
        S21.Detection of TMPRSS2-ERG fusion gene in benign prostate hyperplasia, S. Velaeti, T. Kalogeropoulos, T. Karaolidis*, E. Dimitriadis, K. Kontogianni-Katsarou, A. Savvani, S. Mpisias, S. Stefanakis, N. Pandis, K. Petraki (Athens)
        S22.Serenoa repens. What is the price of the lowering of the IPSS for one point with this herbal extract?, N. Duborija-Kovacevic*, A. Sabo, B. Pajovic (Podgorica, Montenegro; Novi Sad)
        S23.Acute urinary retention due to Benign Prostatic Hyperplasia and single intermittent catheterisation, K. Drasa* (Tirana)
        S24.Risk factors for BPH progression in population of men aged 50 to 80 years, P.Z. Nikic*, D. Nale, O. Durutovic, A. Vuksanovic, S. Micic (Belgrade)
        S25.Volumetry of prostate gland from TRUS images: An automatic method, V. Sakalis*, Ch.R. Gkostsi (Serres, Thessaloniki)
        S26.Prostate contour extraction from TRUS images and 3D model reconstruction: An automatic method, V. Sakalis*, A. Gkotsi (Serres, Thessaloniki)
        S27.Peroxidation processes in mitochondria and microsome of human prostate tissues at different pathology, N. Kvitsinadze*, E. Davitashvili, R. Solomonia, I. Megrelishvili, N. Aleksidze, G. Karazanashvili (Tbilisi)
        S28.The prognostic role of PSA Density in the detection of prostate cancer in men with PSA 4–10 ng/ml and negative both digital rectal examination and transrectal ultrasound, V. Simaioforidis, K. Mitsios, G. Doumanis, S. Kontos*, C. Komninos, M. Karavitakis, S. Koritsiadis (Pireus)
        S29.Transrectal ultrasound-guided prostate biopsy, periprostatic local anesthesia and pain tolerance, M. Hiros, M. Selimovic, H. Spahović*, S. Sadović, E. Spužić (Sarajevo)
        S30.Initial 24-core biopsy improves the detection of clinically significant prostate cancer and high grade prostatic intraepithelial neoplasia in men with PSA less than 10 ng/ml, C. Kostantinidis*, M. Nomikos, I. Kariotis, E. Serafetinidis, D. Volanis, A. Ploumidis, A. McNeill, D. Delakas (Athens; Edinburgh)
        S31.Trans-rectal ultrasound guided prostatic biopsy, Z. Campara*, N. Milovic, S. Cerovic, D. Simic, M. Jovanovic (Belgrade)
        S32.Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series, M. Oderda*, A. Zitella, P. Mondino, C. Fiorito, A. Tizzani, P. Gontero (Turin)
        Tabled 1
        10.40–12.40Poster sessions 3: Incontinence and overactive bladderRoom 3
        S33.Initial experience with the third generation suburethral sling “TVT secur” not as good as it was expected, N. Medojevic*, I. Ignjatovic, D. Basic, M. Potic, A. Dinic, P. Mitic (Nis)
        S34.Complications in the use of mid-urethral tapes and transvaginal meshes in the surgical repair of urinary incontinence and and pelvic organ prolapse in the female, E. Madias*, G. Tombros, I. Georgiopoulos, P. Georgantas, V. Nikolopoulos, D. Karanastasis (Athens)
        S35.Optimal primary minimally invasive treatment for patients with stress urinary incontinence and symptomatic pelvic organ prolapse, M.I. Ignjatovic*, C.N. Medojevic, T.D. Basic, B.M. Potic, L.J.A. Dinic, P.D. Mitic (Nis)
        S36.Transobturatory Tension Free Tape (TOT) procedure in the treatment of female SUI: Controlled trials 2 years after surgical procedures there was no pelvic organ prolapse, J. Ivovic*, D. Tomanovic, D. Kljakic, N. Zejnilovic, Z. Srzentic, S. Vucetic, N. Djurisic, B. Popovic (Bar)
        S37.Long term viscoelastic property assessment of in-vitro aged polypropylene meshes used in female urinary incontinence treatment, N. Ferakis, C. Bouropoulos, N. Bouropoulos, T. Granitsas*, A. Farmakis, I. Poulias (Athens, Patras)
        S38.Urogynecology synthetic grafts in animal studies, M. Potic*, I. Ignjatovic, B. Potic (Nish)
        S39.Minimally invasive therapy of male stress urinary incontinence after radical prostatectomy with the Advance® Sling System, D. Betz*, M. Goepel (Ratingen, Velbert)
        S40.Intensive pelvic floor muscle training after radical prostatectomy improves continence outcomes, A. Zahariou*, A. Kyriakides (Volos)
        S41.A multicenter study on perineal versus penoscrotal approach for implantation of an artificial urinary sphincter: cuff size and control of male stress urinary incontinence, G.D. Henry, S.M. Graham, R.J. Cornell, M.A. Cleves, C.J. Simmons, I. Vakalopoulos*, B. Flynn (Shreveport, La, Kansas City, Ks, Houston, Tx, Little Rock, Ar, Shrevenport,la, Denver, Co; Thessaloniki)
        S42.Transobturator sling technique to treat incontinence in men after prostate operations – our early results, K. Yanev*, D. Ormanov, M. Georgiev, P. Simeonov, P. Dimitrov, V. Mladenov, P. Panchev (Sofia)
        S43.The implantation of Argus adjustable male sling for the treatment of stress urinary incontinence after radical prostatectomy, L. Fasoulis, S. Mpisias, T. Karaolides*, T. Arvanitakis, T. Kalogeropoulos (Athens)
        S44.Adjustable and non adjustable male slings for post-prostatectomy urinary incontinence: The experience of our clinic, A. Konandreas*, E. Koutsiaris, L. Fasoulis, T. Arvanitakis (Athens)
        S45.The role of hyperosmolarity in micturition: physiological model of overactive bladder, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow)
        S46.Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic overactive bladder model rats, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow)
        S47.Alterations in urinary bladder histological structure and mast cells activity following overactive bladder in rats, K. Juszczak*, M. Wyczółkowski, P.J. Thor (Cracow)
        S48.Solifenacin vs oxybutynin: which is desirable to patients with OAB? A randomised, double-blind trial, K. Drasa* (Tirane, Albania)
        S49.Overactive bladder in childhood age – at a crossroad, S.I. Kantchev*, G. Minova, V. Popov (Sofia)
        Tabled 1
        Treatment of male infertility, S. Micic, Belgrade
        Testosterone and the metabolic syndrome, V. Popovic, Belgrade
        Peyronie's disease, A. Kadioglu, Istanbul
        Who needs testosterone substitution and how? N. Sofikitis, Ioannina
        15.20–15.50Coffee break and mounting, viewing of posters
        Tabled 1
        15.20–17.30Posters sessions 4: Testicular cancer, infertility, erectile dysfunctionRoom 1
        S50.Frequency of retroperitoneal metastasis and comparison of pathohistological findings of primary testicular tumor and retroperitoneal metastasis, S. Zivojinov*, M. Zivojinov, N. Dejanovic, S. Vojinov, G. Marusic, D. Jeremic (Novi Sad)
        S51.Management of clinical stage A, B1 and B2 with nonseminomatous testicular tumors avoiding upfront retroperitoneal lymphadenectomy, D. Argirovic*, A. Argirovic (Belgrade)
        S52.Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymphadenectomy after multiple chemotherapy regimens for metastatic nonseminomatous testicular tumors, D. Argirovic*, V. Stanic, A. Argirovic (Belgrade)
        S53.The impact of residual extra-retroperitoneal masses in patients with advanced nonseminomatous testicular tumors, D. Argirovic*, V. Stanic, A. Argirovic (Belgrade)
        S54.Management and outcome of bilateral testicular germ cell tumors in the past decade: experience from large single cancer center, N. Bojanic*, D. Nale, A. Janjic, I. Vukovic, A. Vuksanovic, S. Micic (Belgrade)
        S55.Retroperitoneal lymphadenectomy in treatment of advanced stage nonseminomatous testicular cancer, D. Mocovic*, N. Milovic, V. Bancevic, P. Maric, M. Jovanovic (Belgrade)
        S56.Lymphatics and artery sparing laparoscopic varicocelectomy: an alternative method or a new standard?, A.I. Hinev, D. Anakievski*, S.M. Paunov, S.D. Dyakov, P.K. Chankov, R.I. Raikov (Varna)
        S57.Laparoscopy surgery for varicocele in subfertile men, J. Ivovic* (Bar)
        S58.The impact of L-Carnitine in spermogram of varicocele patients, G. Drenidis*, S. Leontis, L. Leonardopoulos, G. Diamantis, D. Georgoulias, A. Rempelakos (Athens)
        S59.Early use of menotropin in the treatment of varicocele, N. Pakevic*, N. Bojanic, N. Lalic, D. Djordjevic (Valjevo, Belgrade)
        S60.Testicular serum chitotriosidase level in varicocele patients, B. Kuzgunbay*, I. Kurt, M.T. Eren, A. Hasimi, G. Kose, M. Erdal (Ankara)
        S61.Quality of sperm and seminal Zn levels, A. Suhajda*, S. Dragicevic, B. Bojanic, D. Nale, S. Micic (Subotica, Belgrade)
        S62.Effects of recurrence urinary tract infections on the reproduction system of male paraplegics, M. Selimovic*, M. Hiros, H. Spahović, S. Sadović (Sarajevo)
        S63.Ezerex in erectile dysfunction, D. Djordjevic*, D. Nale, S. Micic (Belgrade)
        S64.Interrelationships between erectile dysfunction and smoking in men with hypertension, G. Sakelariou*, C. Vlachopoulos, C. Fasoulakis, N. Ioakeimidis, S. Leontis, K. Rokkas, A. Rempelakos, A. Aggelis, C. Stefanadis (Athens)
        S65.Evidence of increased systemic inflammatory activation in men with intermediate cardiovascular risk and severe penile arterial dysfunction, C. Fasoulakis*, C. Vlachopoulos, G. Sakelariou, N. Ioakeimidis, J. Papazoglou, K. Rokkas, A. Rempelakos, D. Terentes, C. Stefanadis (Athens)
        Tabled 1
        15.20–17.30Posters sessions 5: Kidney cancerRoom 2
        S66.Complicated renal cyst or papillary renal cell carcinoma – a difficult differential diagnosis, M. Ikic*, X. Krah, G. Atanassov, E. Hauschild, G. Eschholz (Blankenhain)
        S67.Is adrenalectomy necessary during radical nephrectomy for renal cell carcinoma?, A. Mickovski*, S. Stavridis, J. Janculev, O. Stankov, L. Lekovski, S. Saidi, V. Filipovski (Skopje)
        S68.Effect of calcimimetic R-568 in apolipoprotein E deficient mice with surgically induced kidney disease, O. Ivanovski*, I. Nikolov, J. Nobuhiko, A. Caudrillier, O. Phan, R. Mentaverri, J. Maizel, Y. Hamada, T. Nguyen-Khoa, M. Fukagawa, M. Kamel, B. Lacour, D. Tilman, Z. Massy (Skopje; Paris, Amiens; Kobe)
        S69.The second step in vitro trial of Ankaferd bloodstopper: comparison with the other hemostatic agents, Glubran 2, Floseal and Celox, E. Huri*, T. Akgül, O. Yücel, M. Astarcı, H. Üstün, C. Germiyanoğlu (Asagiovecler, Ankara, Ankara)
        S70.Benign renal tumor prevalence and its correlation with patient characteristics and pathology report data, S. Tyritzis, K. Sfetsas*, V. Migdalis, K.G. Stravodimos, I. Adamakis, I. Alexopoulos, D. Mitropoulos, C.A. Constantinides (Athens)
        S71.The effect of a novel hemostatic agent, Ankaferd Bloodstopper® (ABS), on renal tubular apoptosis in rat partial nephrectomy model, E. Huri*, T. Akgül, M. Astarcı, H. Üstün, C. Germiyanoğlu (Asagiovecler, Ankara, Ankara)
        S72.Correlation of clinical symptoms and laboratory variables with stage and grade of renal cell carcinoma, S.D. Dyakov*, P.K. Chankov, D. Anakievski, A.I. Hinev (Varna)
        S73.Maspin expression in renal cell carcinoma and its relation to other prognostic parameters, T. Turunc*, N. Bal, A. Dirim, B. Kuzgunbay, U. Gul, H. Ozkardes (Adana, Ankara)
        S74.Renal cell carcinoma metastasis to hand: rare localisations of solitary metastases, R. Mitrovic*, N. Pakevic, B. Jeremic, D. Cesarevic, P. Zivanovic (Valjevo)
        S75.Simplifying partial nephrectomy with the use of Hydro-jet. Reporting on the results from the use of the device in seventeen consecutive cases, A. Archontakis*, P. Voiniadis, Ch. Gekas, P. Nikolopoulos, V. Tzelepis, A. Zarogiannos (Athens)
        S76.Tandem electron microscopic study of the effects of prolonged warm and cold ischemia in an experimental solitary kidney model undergoing partial nephrectomy, S. Tyritzis*, M. Zachariades, K. Evangelou, A. Kyroudi, A. Zervas, I. Alexopoulos, V. Gorgoulis, C.A. Constantinides (Athens)
        S77.Retroperitonoscopic nephrectomy in non-functioned atrophic kidney: preliminary results of 10 cases, E. Huri*, T. Akgül, T. Karakan, C. Germiyanoğlu (Asagiovecler, Ankara)
        S78.Can adjuvant radiotherapy improve the outcome of kidney cancer patients?, V. Frascino*, G. Mantini, G. D’Agostino, A.R. Alitto, M. Balducci, G. Schinzari, M.A. Gambacorta, S. Manfrida, N. Dinapoli, V. Valentini (Rome)
        S79.Bilateral renal carcinoma, B. Milkovic*, Z. Dzamic, M. Djokic, T. Pejcic, N. Bojanic, B. Kajmakovic (Belgrade)
        S80.Application of laparoscopy in combined minimal invasive treatment of urological diseases, S. Tomovic*, I. Vukovic, V. Radojevic, N. Jeremic, A. Vuksanovic, N. Bojanic, S. Micic (Belgrade)
        Tabled 1
        15.20–17.30Posters sessions 6: Prostate cancerRoom3
        S81.Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis, O. Sanli, C. Kucukgergin, M. Gokpinar, T. Tefik*, I. Nane, S. Seckin (Istanbul)
        S82.Prostate brachytherapy: Experience from 300 cases, T. Kalogeropoulos, E. Koutsiaris, S. Mpisias*, L. Fasoulis, A. Konandreas, A. Marketakis (Athens)
        S83.Prognostic value of immunohistochemical expression of MMP-2, MMP-9 and TIMP-1 in radical prostatectomy specimens, A. Sen*, H.A. Atalay, Z. Zemheri (Istanbul, Diyarbakir)
        S84.Standard vs extended pelvic lymph node dissection for prostate cancer. Does it improve tumour staging?, A. Anastasiadis*, G. Dimitriadis, G. Gkotsos, K. Tzakas, D. Radopoulos (Thessaloniki)
        S85.Osteosclerotic metastases of prostate cancer concomitant to peripheral motor neuropathy, G. Vyshka*, F. Tartari (Tirana)
        S86.Results from the first phase I clinical study of the novel Ii-Key/HER-2(776–790) hybrid peptide vaccine in patients with prostate cancer, S. Mpisias*, T. Kalogeropoulos, E. Koutsiaris, A. Rempelakos, A. Konandreas, K. Georgakopoulou, S. Perez, K. Baxevanis, T. Arvanitakis, A. Thanos (Athens)
        S87.Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity, E. Mazzeo*, G. Mantini, V. Frascino, G.C. Mattiucci, N. Dinapoli, S. Fersino, L. Tagliaferri, A. Morganti, C.G. Rinaldi, E. Ciurlia, S. Luzi, N. Cellini (Rome)
        S88.Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment?, C.G. Rinaldi*, G. Mantini, M. Balducci, G.R. D’agostino, G.C. Mattiucci, V. Frascino, L. Tagliaferri, N. Dinapoli, S. Fersino, F. Miccichè, L. Azario, N. Cellini (Rome)
        S89.Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8), M. Sunay*, L. Emir, A. Karabulut, M. Dadalı, D. Erol (Ankara)
        S90.Urethral PSA production after radical prostatectomy, T. Pejcic*, N. Lalic, B. Glisic, C. Tulic, B. Milkovic, J. Hadzi-Djokic (Belgrade)
        S91.Using image guided radiotherapy for prostatic cancer treatment, N. Dinapoli*, G.C. Mattiucci, E. Ciurlia, M. Balducci, G. Mantini, V. Frascino, G.R. D’agostino, S. Fersino, C.G. Rinaldi, E. Mazzeo, L. Tagliaferri, N. Cellini (Roma)
        S92.Impact of radiation therapy plus hormonal therapy in patients affected by high risk prostate cancer, G.C. Mattiucci*, G. Mantini, G. De Dilectis, V. Frascino, L. Tagliaferri, N. Dinapoli, S. Luzi, D. Smaniotto, S. Fersino, E. Mazzeo, E. Ciurlia, N. Cellini (Rome)
        S93.The modified terminologia Anatomica of the nerve sparing laparoscopic radical prostatectomy: important landmarks of the procedure related with functional anatomy, E. Huri*, I. Tatar, M. Sargon, C. Germiyanoğlu, R. Başar (Asagiovecler, Ankara)
        S94.Inguinal hernia in men undergoing sectio alta surgical approach, S. Stavridis*, A. Mickovski, J. Janculev, S. Saidi, S. Dohcev, L. Lekovski (Skopje)
        S95.Relationship between obesity and prostate cancer at the time of biopsy, G. Drenidis*, J. Papazoglou, D. Savidis, G. Diamantis, G. Sakelariou, S. Leontis, A. Rempelakos (Athens)
        Tabled 1
        17.00–17.30State of the Art Lecture: Have we solved the problem of anterior urethral stricture disease?
        Ch. Chapple, Sheffield
        Improving TUR-B

        Saturday, 10 October 2009

        Tabled 1
        08.00–09.40Paediatric urology
        Antenatal diagnosis, S. Giannopoulos, Alexandroupolis
        Congenital abnormalities are changing, F. Tartari, Tirana
        VU.Reflux: Sting or reconstruction, G. Tsachouridis, Athens
        Management of hypospadias, M. Djordjevic, Belgrade
        Voiding dysfunction, S. Tekgül, Ankara
        09.40–10.20Coffee break and mounting, viewing of posters
        Tabled 1
        09.40–11.40Poster sessions 7: Stone diseaseRoom 1
        S96.Epidemiologic characteristics of urolithiasis in Turkey: Update in 2009, M. Binbay, A.Y. Muslumanoglu, E. Yuruk*, T. Akman, Y. Berberoglu, T. Esen, A. Tefekli (Istanbul)
        S97.The effect of metabolic syndrome components on urolithiasis: An epidemiological study, M. Binbay, E. Yuruk*, T. Akman, Y. Berberoglu, M. Baykal, A.Y. Muslumanoglu, A. Tefekli (Istanbul)
        S98.Effect of the stone and patient related parameters on time duration of percutaneous nephrolitotomy operation and the length of hospitalization: Analysis of 1466 patients, T. Akman, E. Sari, M. Binbay, E. Yuruk*, M. Kaba, R. Aslan, M. Baykal, O. Sarilar, A.Y. Muslumanoglu, A. Tefekli (Istanbul)
        S99.Percutaneous nephrolithotomy for staghorn kidney stones in geriatric patients, B. Kuzgunbay*, T. Turunc, U. Gul, O. Yaycioglu, M.T. Egilmez, H. Ozkardes (Ankara)
        S100.Long term renal function and stone recurrence after percutaneous nephrolithotomy in patients with renal insufficiency, B. Kuzgunbay*, U. Gul, T. Turunc, H. Ozkardes, O. Yaycioglu (Ankara)
        S101.Ultrasound guided percutaneous pneumatic lithotripsy, V. Radojevic*, N. Jeremic, S. Tomovic, B. Vavic, A. Milosevic (Belgrade)
        S102.Percutaneous nephrolithotripsy and shockwave lithotripsy in the treatment of staghorn kidney lithiasis, K. Petkova*, I. Saltirov, T. Petkov (Sofia)
        S103.Outcome of percutaneous management of staghorn calculi: can the access number be predicted?, T. Akman, E. Sari, M. Binbay, E. Yuruk*, A.K. Tepeler, Y. Berberoglu, A.Y. Muslumanoglu, A. Tefekli (Istanbul)
        S104.Nomogram for prediction of fever after PCNL, M. Bazardzanovic*, S. Tomovic, N. Jeremic, I. Vukovic (Mostar; Belgrade)
        S105.Does stone burden and degree of hydronephrosis affect success of shock wave lithotripsy in pediatric patients?, T. Turunc*, M. Gonen, B. Kuzgunbay, U.T. Bilgilisoy, A. Dirim, M.I. Tekin, H. Ozkardes (Ankara)
        S106.Changes of plasma β-endorphin and ACTH levels during ESWL treatment, M. Sunay*, A. Karabulut, M. Dadalı, L. Emir, D. Erol (Ankara)
        S107.ESWL monotherapy as primary modality of treating upper uretheral stones, E. Bezhani*, R. Domi, B. Hoxha, F. Tartari (Tirana)
        S108.Omnic Tocas in complex treatment of urolithiasis, M. Georgiev, D. Ormanov, V. Vassilev, K. Bonev, P. Dimitrov, V. Mladenov*, K. Yanev, A. Filev, P. Simeonov, P. Panchev (Sofia)
        S109.Ureterolithotripsy with the Stonebreaker™ system, L. Leonardopoulos*, A. Leventis, S. Leontis, G. Sakelariou, J. Papazoglou, A. Rempelakos (Athens)
        S110.Ureteroscopy in the management of pediatric ureteral stones, T. Turunc, B. Kuzgunbay*, U. Gul, U.T. Bilgilisoy, C. Aygun, H. Ozkardes (Ankara)
        S111.Management of ureteral calculi: shockwave lithotripsy or ureteroscopy?, K. Petkova*, I. Saltirov, T. Petkov (Sofia)
        S112.Comparative evaluation of pneumatic versus holmium: YAG laser lithotripsy for impacted ureteral stones, M. Binbay, A. Tepeler, E. Yuruk*, O. Sarilar, U. Ozkuvanci, A.Y. Muslumanoglu (Istanbul)
        S113.The experiences in laparoscopic ureterolithotomy: multicentric analysis of cases, based on “Turkurolap Group”, E. Huri*, E. Başok, O. Uğurlu, C. Gürbüz, T. Akgül, S. Bedir, Y. Özgök (Asagiovecler, Ankara, İstanbul)
        S114.Frequency of urolithiasis in primary gout, Z. Radosavljevic*, D. Milenkovic, N. Radosavljevic (Mladenovac, Belgrade)
        Tabled 1
        09.40–11.40Poster sessions 8: Trauma and reconstructionRoom 2
        S115.Use of urinary beta-2 microglobulin (B2MG) as renal injury index, S. Kontos*, G. Lefakis, V. Politis, V. Simaioforidis, M. Karavitakis, S. Koritsiadis (Piraeus)
        S116.Urethral injury. Can mechanism of injury prejudge partial or total urethral rupture?, V. Simaioforidis, G. Lefakis, V. Politis, S. Kontos*, C. Komninos, S. Koritsiadis (Pireus)
        S117.In-vivo haemostatic effect of Ankaferd Bloodstopper in rat major renal trauma model: controlled trial of novel haemostatic agent, C. Germiyanoğlu, E. Huri*, T. Akgül, A. Ayyıldız, H. Üstün (Ankara, Asagiovecler)
        S118.Testicular injuries, conseqences and medicolegal significance, D. Crnomarkovic*, S. Micic (Belgrade)
        S119.Controversies in penile fracture treatment, D. Mandic, B. Pajovic*, M. Radovic, M. Radunovic (Podgorica)
        S120.Penile fracture – Series of cases, S. Saidi*, D. Petrovski, S. Dohcev, O. Stankov, M. Penev, S. Stavridis, A. Mickovski, J. Janculev, I. Ognen, L. Lekovski, V. Georgiev, Z. Popov (Skopje)
        S121.Patients with vaginal agenesis (Mayer–Rokitansky–Küster–Hauser syndrome) – their psychosocial and psychosexual aspects after reconstructive surgery, M. Bizic*, L. Labus, D. Stanojevic, M.L. Djordjevic (Belgrade)
        S122.Feminizing reconstruction of the external genitalia in childhood age, S. Tshanatshev, G. Minova*, V. Popov, S. Peev, E. Atanasov (Sofia)
        S123.One stagemetoidioplasty in female to male transgender patients: the role of genital flaps for urethral reconstruction, M. Bizic*, M. Majstorovic, V. Kojovic, D. Stanojevic, G. Korac, B. Stojanovic, M.L. Djordjevic (Belgrade)
        S124.Combined total phalloplasty and metoidioplasty as a single stage procedure in female to male gender reassignment surgery, V. Kojovic*, M. Bizic, M. Majstorovic, S. Kojic, D. Stanojevic, G. Korac, M. Djordjevic (Belgrade)
        S125.Functional and esthetic reduction of hyperthrophied labia minora, M. Bizic*, V. Kojovic, M. Majstorovic, G. Korac, M.L. Djordjevic (Belgrade)
        S126.Our experience in treating 27 genito-urinary fistulas during 2002–2008 in regional Shkodra hospital, Albania, L. Bajri, S. Ymeri, I. Shani, F. Tartari, E. Bezhani, A. Ndoi, B. Pesha, G. Galiqi* (Shkoder)
        S127.Hanged ventral buccal mucosa graft in the treatment of urethral stricture after failed hypospadias repair, V. Kojovic*, M. Majstorovic, M. Bizic, S. Ducic, G. Korac, M. Djordjevic (Belgrade)
        S128.Reconstructive urethral surgery for residual hypospadias and/or complications after failed hypospadias repair in childhood, V.A. Voinescu*, N. Iordan (Bucuresti)
        S129.Treatment of proximal hypospadias using extended snodgrass technique with dorsal dartos flap wraping, M. Majstorovic*, M. Bizic, V. Kojovic, B. Stojanovic, Z. Krstic, M. Djordjevic (Belgrade)
        S130.Real incidence of penile curvature in hypospadias, M. Majstorovic*, V. Kojovic, M. Bizic, B. Stojanovic, G. Korac, Z. Krstic, M. Djordjevic (Belgrade)
        Tabled 1
        09.40–11.40Poster sessions 9: MiscellaneousRoom 3
        S131.Antimicrobial susceptibility in Gram-negative nosocomial retroperitoneal infections, M. Stojadinovic*, D.D. Baskic, R.D. Milovanovic, M.S. Jankovic (Kragujevac; Kragujevac)
        S132.Clinical and economic considerations of treatments of uncomplicated urinary tract infections (UTIs) in Albanian clinical practice, A. Kaleci*, S. Vito, F. Tartari (Tirana)
        S133.Two surveys of prevalence of nosocomial urinary tract infection in urology, G. Kasmi*, B. Byku, M. Xhani, F. Tartari, E. Bezhani (Tirana)
        S134.Management of the emphysematous pyelonephritis in adult patients, T. Turunc*, B. Kuzgunbay, T. Tokmak, T. Turunc, H. Ozkardes (Adana, Ankara)
        S135.Bacterial colonization of percutaneous nephrostomy, L.J. Dinic*, I. Ignjatovic, J. Stankovic, I. Stojkovic, P. Mitic (Nis)
        S136.CT urography: clinical indications, limitations and radiation dose: a proposed approach, I. Georgiopoulos*, E. Tsagkatakis, F. Nikolakakos, G. Neofitou, I. Fragioudaki, F. Laspas, K. Sotirakou, D. Karanastasis (Athens)
        S137.Urological complications of kidney transplantation: 13 years’ experience, M. Jovanovic*, N. Milovic, Z. Campara, V. Bancevic, P. Maric, A. Spasic, D. Simic (Belgrade)
        S138.Evaluation of pain perception in patients undergoing transurethral procedures under general or epidural anaesthesia, S. Tyritzis, K.G. Stravodimos, A. Alevizopoulos*, V. Migdalis, I. Adamakis, D. Mitropoulos, C.A. Constantinides (Athens)
        S139.Evaluation of the postsurgical pain management after urological surgery, G. Atanassov*, M. Ahrens, X. Krah, M. Ikic, E. Hauschild, M. Worm, G. Eschholz (Blankenhain)
        S140.The use of bupivacaine with morphine or neostigmine, H. Gani*, R. Domi, M. Xhani, I. Ohri, E. Cobani, A. Janko, B. Hoxha (Tirana)
        S141.Preoperative use of ketamine for treatment of acute postoperative pain, H. Gani*, R. Domi, M. Xhani, I. Ohri, A. Janko, B. Hoxha, E. Cobani (Tirana)
        S142.Complications of neuraxial blocks in urology, our 10-year experience, R. Domi*, I. Ohri, M. Xhani, A. Dyrmishi, H. Gani (Tirana)
        S143.Sufentanyl vs fentanyl postoperative morphine sparing effect in urologic surgery, R. Domi*, H. Gani, A. Dyrmishi, A. Janko, B. Hoxha, M. Xhani (Tirana)
        S144.The risk of second urogenital primary cancer in patients with intestinal carcinoids, K. Zougkas, V. Papadopoulos*, I. Georgopoulos, E. Fragkiadis, A. Petas, T. Sotrillis, I. Papanastasopoulos, T. Papavasilliou (Rhodes)
        Tabled 1
        11.40–12.30Panel Debate: Are we overdiagnosing prostate cancer?
        Chair: Ch. Chapple, Sheffield
        Panelists: H.Özen, Ankara; S. Stavridis, Skopje, G. Marusic, Novi Sad
        ∼12.30Awards and closing remarks
        S. Micic, Belgrade
        M. Marberger, Vienna